Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Viemed Healthcare Announces Second Quarter 2026 Financial Results
Viemed Healthcare reported Q2 2026 revenue of $78.1 million, a company record and a 23.9% increase year-over-year, driven by record ventilator and PAP therapy patient counts.
The company generated $8.6 million in free cash flow during the quarter and repurchased 530,802 shares for $5.1 million, while maintaining $46 million in available credit.
Management raised the low end of its full-year revenue guidance to $314 million and revised Adjusted EBITDA expectations to a range of $64 million to $68 million, citing strong operating trends.